Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Nephros, Inc. (NEPH)
USD3.65
+0.10 (+2.82%)
US NASDAQ Healthcare Medical - Instruments & Supplies
Address
380 Lackawanna Place 7079
South Orange, NJ, US
South Orange, NJ, US
CEO
Robert Banks
Website
nephros.com
IPO
2004-09-21
CIK 1196298 ISIN US6406714005
Description
Nephros, Inc. is a company that specializes in developing and marketing sophisticated water purification solutions across the United States, catering to both the medical and commercial sectors. Its operations are structured into three primary segments: Water Filtration, Pathogen Detection, and Renal Products. Within its Water Filtration division, Nephros offers advanced ultrafiltration products. These are vital in dialysis centers for eradicating biological contaminants from water and bicarbonate concentrate, and are also deployed in hospitals to prevent infections from waterborne pathogens such as Legionella and Pseudomonas. Their utility extends to military installations, outdoor recreation, commercial establishments, and various other healthcare facilities. The Pathogen Detection segment focuses on developing and distributing real-time water testing systems, which deliver critical, actionable data regarding waterborne pathogens. Furthermore, under its Renal Products segment, the company provides medical devices designed for individuals suffering from renal disease, notably including a second-generation hemodiafiltration system tailored for patients with end-stage renal disease. Additionally, Nephros markets a range of water filters under the Nephros and AETHER brands. These filters are engineered not only to enhance water taste and eliminate odors but also to significantly reduce biofilm, bacteria, and scale accumulation in downstream equipment, serving the food service, hospitality, convenience store, and healthcare industries. Established in 1997, Nephros, Inc. maintains its corporate headquarters in South Orange, New Jersey.
News Sentiment (7d)
Based on only 2 articles — low confidence
- �Nephros Announces Inclusion in the Russell Microcap® Index MCAP MediaWire
- Nephros Announces Inclusion in the Russell Microcap® Index GlobeNewsWire
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD3.65
+0.10 (+2.82%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
23.4K
Beta
1.49
Float Shares
9.43M
Free Float %
86.9%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -16.19% | -6.65% | -0.34% | -26.98% | -31.87% | -39.55% | +42.51% | +103.45% | -63.71% | -6.35% | -99.72% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (4 ratings, all time)
Buy
Price Targets & DCF
Current price
3.65
Ratings Trend (MoM)
100% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 2 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
-4.77
Distress
Piotroski F-Score
3 / 9
Average
MOAT Score
4 / 10
Developing
Composite Rating
B
Overall Score
3 / 5
Medium
DCF Score
1 / 5
Low
ROE Score
4 / 5
High
ROA Score
5 / 5
High
D/E Score
3 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
2 / 5
Medium
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Instruments & Supplies: +7.9%+32.7% ★ Q1'26: +6.9% (vs Q1'25)
-
EPS growth Medical - Instruments & Supplies: +16.3%+1,471.4% ★ Q1'26: -75.9% (vs Q1'25)
-
FCF margin FCF growth · Medical - Instruments & Supplies: +27.1%+4.6% Q1'26: -32.1% (vs Q1'25)
-
EBIT margin Medical - Instruments & Supplies: +13.5%+6.1% Q1'26: +1.9% (vs Q1'25)
-
ROIC Medical - Instruments & Supplies: +6.0%+19.4% ★ Q1'26: +5.1% (vs Q1'25)
-
Share dilution Medical - Instruments & Supplies: +0.1%+3.5% Q1'26: +3.5% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Instruments & Supplies: -0.24×0.83× ★ Q1'26: 1.92× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
1.94M
est: 2.00M (-2.8%)
|
2.32M
est: 5.40M (-57.0%)
|
3.81M
est: 10.90M (-65.1%)
|
5.69M
est: 18.00M (-68.4%)
|
10.33M
est: 10.02M (+3.2%)
|
8.56M
est: 8.59M (-0.4%)
|
10.22M
est: 10.47M (-2.5%)
|
9.98M
est: 10.29M (-3.1%)
|
14.24M
est: 13.77M (+3.4%)
|
14.16M
est: 14.18M (-0.1%)
|
18.79M
est: 18.51M (+1.5%)
|
20.60M
20.60M – 20.60M
+11.3% YoY
|
23.13M
23.13M – 23.13M
+12.2% YoY
|
| EBITDA |
-2.83M
est: -473.7K (-498.3%)
|
-2.63M
est: -1.28M (-105.6%)
|
-2.08M
est: -2.58M (+19.5%)
|
-3.08M
est: -4.26M (+27.7%)
|
-3.01M
est: -2.37M (-26.8%)
|
-4.21M
est: -2.04M (-106.7%)
|
-2.49M
est: -4.00M (+37.7%)
|
-3.69M
est: -4.74M (+22.3%)
|
-1.36M
est: -1.72M (+21.0%)
|
227.0K
est: -1.77M (+112.8%)
|
1.29M
est: -2.31M (+155.6%)
|
-2.57M
-2.57M – -2.57M
-11.3% YoY
|
-2.89M
-2.89M – -2.89M
-12.2% YoY
|
| EBIT |
-3.05M
est: -526.1K (-479.0%)
|
-2.86M
est: -1.42M (-101.4%)
|
-2.30M
est: -2.87M (+19.9%)
|
-3.25M
est: -4.73M (+31.4%)
|
-3.21M
est: -2.64M (-21.8%)
|
-4.42M
est: -2.26M (-95.4%)
|
-2.74M
est: -4.69M (+41.5%)
|
-4.26M
est: -4.88M (+12.7%)
|
-1.57M
est: -2.03M (+22.6%)
|
90.0K
est: -2.09M (+104.3%)
|
1.15M
est: -2.73M (+141.9%)
|
-3.04M
-3.04M – -3.04M
-11.3% YoY
|
-3.42M
-3.42M – -3.42M
-12.2% YoY
|
| Net Income |
-3.09M
est: -7.63M (+59.5%)
|
-3.03M
est: -3.82M (+20.6%)
|
-809.0K
est: 2.86M (-128.3%)
|
-3.40M
est: 7.63M (-144.6%)
|
-3.42M
est: -5.80M (+41.0%)
|
-4.77M
est: -5.83M (+18.3%)
|
-4.11M
est: -4.32M (+4.8%)
|
-7.38M
est: -2.86M (-158.6%)
|
-1.58M
est: -1.35M (-16.4%)
|
74.0K
est: 109.7K (-32.5%)
|
1.19M
est: 1.21M (-1.0%)
|
504.0K
504.0K – 504.0K
-58.2% YoY
|
1.10M
1.10M – 1.10M
+117.6% YoY
|
| SGA |
3.44M
est: 1.36M (+154.0%)
|
2.85M
est: 3.66M (-22.0%)
|
3.30M
est: 7.39M (-55.4%)
|
4.52M
est: 12.20M (-63.0%)
|
6.12M
est: 6.79M (-9.9%)
|
6.47M
est: 5.82M (+11.0%)
|
7.20M
est: 8.48M (-15.1%)
|
7.59M
est: 7.94M (-4.4%)
|
8.91M
est: 8.57M (+4.0%)
|
7.68M
est: 8.83M (-13.0%)
|
9.00M
est: 11.52M (-21.9%)
|
12.82M
12.82M – 12.82M
+11.3% YoY
|
14.40M
14.40M – 14.40M
+12.2% YoY
|
| EPS |
-0.80
est: -0.72 (-11.1%)
|
-0.56
est: -0.36 (-55.6%)
|
-0.14
est: 0.27 (-151.9%)
|
-0.50
est: 0.72 (-169.4%)
|
-0.42
est: -0.55 (+23.2%)
|
-0.52
est: -0.55 (+5.5%)
|
-0.41
est: -0.42 (+1.6%)
|
-0.72
est: -0.70 (-3.6%)
|
-0.15
est: -0.12 (-21.6%)
|
0.01
est: 0.01 (-30.0%)
|
0.11
est: 0.11 (+0.0%)
|
0.05
0.05 – 0.05
-58.2% YoY
|
0.10
0.10 – 0.10
+117.6% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-07 | B | 3/5 | 1/5 | 4/5 | 5/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-06 | B | 3/5 | 1/5 | 4/5 | 5/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-05 | B | 3/5 | 1/5 | 4/5 | 5/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-04 | B | 3/5 | 1/5 | 4/5 | 5/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-01 | B- | 3/5 | 1/5 | 4/5 | 5/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-30 | B- | 3/5 | 1/5 | 4/5 | 5/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-29 | B- | 3/5 | 1/5 | 4/5 | 5/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-28 | B- | 3/5 | 1/5 | 4/5 | 5/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-27 | B- | 3/5 | 1/5 | 4/5 | 5/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-24 | B- | 3/5 | 1/5 | 4/5 | 5/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-23 | B- | 3/5 | 1/5 | 4/5 | 5/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-22 | B- | 3/5 | 1/5 | 4/5 | 5/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-21 | B- | 3/5 | 1/5 | 4/5 | 5/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-20 | B- | 3/5 | 1/5 | 4/5 | 5/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-17 | B- | 3/5 | 1/5 | 4/5 | 5/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-16 | B- | 3/5 | 1/5 | 4/5 | 5/5 | 2/5 | 1/5 | 2/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
25.3K
OE per share TTM
0.00
Owner's Yield
0.07%
Maintenance CapEx ratio
24.76%
Maint CapEx / Avg PPE
10.3%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
1
Total invested
357.6K
Insider transactions (90d)
0
Beneficial owners (>5%)
20
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Charles E. Davidson | 30.13M | 61.99% | — | 30.13M | — | 10.00 | IN | United States | 2016-01-14 | ↗ |
| 2 | Joseph M. Jacobs | 30.13M | 61.99% | — | 30.13M | — | 10.00 | IN | United States | 2016-01-14 | ↗ |
| 3 | Wexford Capital LP | 30.13M | 61.99% | — | 30.13M | — | 10.00 | PN | Delaware | 2016-01-14 | ↗ |
| 4 | Wexford GP LLC | 30.13M | 61.99% | — | 30.13M | — | 10.00 | OO | Delaware | 2016-01-14 | ↗ |
| 5 | Lambda Investors LLC | 29.80M | 61.48% | — | 29.80M | — | 10.00 | OO | Delaware | 2016-01-14 | ↗ |
| 6 | Cowen Prime Advisors LLC | 1.43M | 4.00% | — | — | — | 1.43M | IA | Citizenship or Place of Organization | 2023-02-03 | ↗ |
| 7 | HOWARD GOLDEN | 1.29M | 11.90% | — | 1.29M | — | 10.00 | IN | : | 2011-03-24 | ↗ |
| 8 | KEVIN WYMAN | 1.29M | 11.90% | — | 1.29M | — | 10.00 | IN | : | 2011-03-24 | ↗ |
| 9 | SOUTHPAW ASSET MANAGEMENT LP | 1.29M | 11.90% | — | 1.29M | — | 10.00 | PN | : | 2011-03-24 | ↗ |
| 10 | SOUTHPAW HOLDINGS LLC | 1.29M | 11.90% | — | 1.29M | — | 10.00 | OO | : | 2011-03-24 | ↗ |
| 11 | Andrew N. Wiener | 550.0K | 5.60% | — | 550.0K | — | 550.0K | IN | Delaware | 2020-10-21 | ↗ |
| 12 | Samjo Capital, LLC | 550.0K | 5.60% | — | 550.0K | — | 550.0K | OO | Delaware | 2020-10-21 | ↗ |
| 13 | Samjo Management, LLC | 550.0K | 5.60% | — | 550.0K | — | 550.0K | IA, OO | Delaware | 2020-10-21 | ↗ |
| 14 | Ian Cassel | 525.4K | 5.12% | 525.4K | — | — | — | IA | Intelligent Fanatics Capital Management LLC Pennsylvania Ian Cassel USA | 2022-02-28 | ↗ |
| 15 | Sandra F. Pessin | 489.4K | 5.00% | 489.4K | — | 489.4K | 11.00 | IN | — | 2020-10-21 | ↗ |
| 16 | Evans | 478.9K | 4.70% | 478.9K | — | 478.9K | — | IN | States of America | 2021-06-11 | ↗ |
| 17 | SOUTHPAW CREDIT OPPORTUNITY MASTER FUND LP | 442.7K | 8.80% | — | 442.7K | — | 10.00 | OO | : | 2011-03-24 | ↗ |
| 18 | Norman H. Pessin | 217.7K | 2.20% | 217.7K | — | 217.7K | 11.00 | IN | — | 2020-10-21 | ↗ |
| 19 | Brian L. Pessin | 174.6K | 1.80% | 174.6K | — | 174.6K | 11.00 | IN | — | 2020-10-21 | ↗ |
| 20 | Cowen Prime Advisors, a division of Cowen Prime Services LLC | — | 0.00% | — | — | — | — | BD, IA | Citizenship or Place of Organization | 2022-02-10 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
1
-34 vs prev Q
New positions
0
Closed positions
34
Increased
1
Reduced
0
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | WEXFORD CAPITAL LP | 3.62M +— (+0.0%) | 17.65M +542.6K (+3.2%) | 34.08% -0.037 pp | 3.40% +0.946 pp | USD5.85 -16.6% | 17 qtrs — |
| 2 | TOPLINE CAPITAL MANAGEMENT, LLC | 614.3K +18.0K (+3.0%) | 3.00M +177.3K (+6.3%) | 5.79% +0.164 pp | 0.27% -0.214 pp | USD2.44 +100.0% | 5 qtrs — |
| 3 | VANGUARD GROUP INC | 233.6K -47.7K (-16.9%) | 1.14M -190.4K (-14.3%) | 2.20% -0.452 pp | 0.00% +0.000 pp | USD4.41 +10.7% | 24 qtrs — |
| 4 | BARD ASSOCIATES INC | 121.6K -5.5K (-4.3%) | 593.5K -7.8K (-1.3%) | 1.15% -0.053 pp | 0.15% -0.007 pp | USD6.13 -20.4% | 24 qtrs — |
| 5 | RENAISSANCE TECHNOLOGIES LLC | 103.8K +21.3K (+25.8%) | 506.4K +116.2K (+29.8%) | 0.98% +0.200 pp | 0.00% +0.000 pp | USD4.69 +4.1% | 3 qtrs — |
| 6 | GEODE CAPITAL MANAGEMENT, LLC | 74.6K -1.3K (-1.7%) | 364.3K +5.2K (+1.5%) | 0.70% -0.013 pp | 0.00% +0.000 pp | USD1.97 +147.7% | 16 qtrs — |
| 7 | CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC. | 69.1K +69.1K (+100.0%) | 337.0K +337.0K (+100.0%) | 0.65% +0.652 pp | 0.00% +0.001 pp | USD4.88 +0.0% | 1 qtrs NEW |
| 8 | HIGHTOWER ADVISORS, LLC | 59.7K +4.0K (+7.2%) | 291.4K +27.9K (+10.6%) | 0.56% +0.037 pp | 0.00% +0.000 pp | USD9.00 -45.8% | 25 qtrs — |
| 9 | MESIROW FINANCIAL INVESTMENT MANAGEMENT, INC. | 50.0K +36.2K (+262.3%) | 244.0K +178.7K (+273.8%) | 0.47% +0.341 pp | 0.01% +0.004 pp | USD4.49 +8.7% | 9 qtrs — |
| 10 | ESSEX INVESTMENT MANAGEMENT CO LLC | 39.0K +14.2K (+57.1%) | 190.2K +72.8K (+62.0%) | 0.37% +0.133 pp | 0.03% +0.011 pp | USD4.38 +11.4% | 3 qtrs — |
| 11 | BLAIR WILLIAM & CO/IL | 36.2K +— (+0.0%) | 176.9K +5.4K (+3.2%) | 0.34% 0.000 pp | 0.00% +0.000 pp | USD8.07 -39.5% | 26 qtrs — |
| 12 | NAVELLIER & ASSOCIATES INC | 27.2K +27.2K (+100.0%) | 132.6K +132.6K (+100.0%) | 0.26% +0.256 pp | 0.01% +0.015 pp | USD4.88 +0.0% | 1 qtrs NEW |
| 13 | DE LISLE PARTNERS LLP | 25.0K +25.0K (+100.0%) | 122.0K +122.0K (+100.0%) | 0.24% +0.236 pp | 0.02% +0.016 pp | USD4.88 +0.0% | 1 qtrs NEW |
| 14 | QUADRATURE CAPITAL LTD | 23.0K +23.0K (+100.0%) | 112.3K +112.3K (+100.0%) | 0.22% +0.217 pp | 0.00% +0.001 pp | USD4.88 +0.0% | 1 qtrs NEW |
| 15 | MARSHALL WACE, LLP | 22.0K +22.0K (+100.0%) | 107.3K +107.3K (+100.0%) | 0.21% +0.207 pp | 0.00% +0.000 pp | USD4.88 +0.0% | 1 qtrs NEW |
| 16 | XTX TOPCO LTD | 21.6K +7.1K (+48.5%) | 105.5K +36.6K (+53.2%) | 0.20% +0.066 pp | 0.00% -0.001 pp | USD4.78 +2.1% | 2 qtrs — |
| 17 | CITADEL ADVISORS LLC | 20.7K +4.2K (+25.2%) | 101.1K +22.8K (+29.1%) | 0.20% +0.039 pp | 0.00% +0.000 pp | USD3.18 +53.5% | 7 qtrs — |
| 18 | GOLDMAN SACHS GROUP INC | 19.0K +337.0 (+1.8%) | 92.6K +4.4K (+5.0%) | 0.18% +0.003 pp | 0.00% +0.000 pp | USD4.73 +3.2% | 2 qtrs — |
| 19 | MORGAN STANLEY | 18.0K +16.0K (+837.8%) | 87.6K +78.6K (+867.5%) | 0.17% +0.151 pp | 0.00% +0.000 pp | USD4.76 +2.5% | 24 qtrs — |
| 20 | STATE STREET CORP | 15.7K +— (+0.0%) | 76.6K +2.4K (+3.2%) | 0.15% 0.000 pp | 0.00% +0.000 pp | USD1.53 +219.0% | 15 qtrs — |
| 21 | PRELUDE CAPITAL MANAGEMENT, LLC | 15.2K +15.2K (+100.0%) | 74.1K +74.1K (+100.0%) | 0.14% +0.143 pp | 0.01% +0.006 pp | USD4.88 +0.0% | 1 qtrs NEW |
| 22 | DIMENSIONAL FUND ADVISORS LP | 13.6K +— (+0.0%) | 66.4K +2.0K (+3.2%) | 0.13% 0.000 pp | 0.00% +0.000 pp | USD4.73 +3.2% | 2 qtrs — |
| 23 | HERON BAY CAPITAL MANAGEMENT | 13.5K +13.5K (+100.0%) | 65.7K +65.7K (+100.0%) | 0.13% +0.127 pp | 0.01% +0.013 pp | USD4.88 +0.0% | 1 qtrs NEW |
| 24 | SPEARS ABACUS ADVISORS LLC | 11.0K +11.0K (+100.0%) | 53.7K +53.7K (+100.0%) | 0.10% +0.104 pp | 0.00% +0.001 pp | USD4.88 +0.0% | 1 qtrs NEW |
| 25 | CENTIVA CAPITAL, LP | 10.8K +10.8K (+100.0%) | 52.9K +52.9K (+100.0%) | 0.10% +0.102 pp | 0.00% +0.000 pp | USD4.88 +0.0% | 1 qtrs NEW |
| 26 | NORTHERN TRUST CORP | 10.8K +10.8K (+100.0%) | 52.8K +52.8K (+100.0%) | 0.10% +0.102 pp | 0.00% +0.000 pp | USD4.88 +0.0% | 1 qtrs NEW |
| 27 | ELKHORN PARTNERS LIMITED PARTNERSHIP | 7.0K -5.5K (-44.0%) | 34.2K -25.0K (-42.2%) | 0.07% -0.052 pp | 0.02% -0.019 pp | USD3.08 +58.4% | 25 qtrs — |
| 28 | KESTRA ADVISORY SERVICES, LLC | 6.0K +6.0K (+100.0%) | 29.4K +29.4K (+100.0%) | 0.06% +0.057 pp | 0.00% +0.000 pp | USD4.88 +0.0% | 1 qtrs NEW |
| 29 | ADVISOR GROUP HOLDINGS, INC. | 1.6K +1.5K (+828.6%) | 7.9K +7.1K (+858.9%) | 0.02% +0.014 pp | 0.00% +0.000 pp | USD4.79 +1.9% | 3 qtrs — |
| 30 | ROYAL BANK OF CANADA | 738.00 +738.0 (+100.0%) | 4.0K +4.0K (+100.0%) | 0.01% +0.007 pp | 0.00% +0.000 pp | USD4.88 +0.0% | 1 qtrs NEW |
| 31 | SAGEVIEW ADVISORY GROUP, LLC | 590.00 +590.0 (+100.0%) | 2.9K +2.9K (+100.0%) | 0.01% +0.006 pp | 0.00% +0.000 pp | USD4.88 +0.0% | 1 qtrs NEW |
| 32 | BANK OF AMERICA CORP /DE/ | 73.00 -19.0 (-20.7%) | 356.00 -79.0 (-18.2%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD2.73 +78.8% | 9 qtrs — |
| 33 | HARBOUR INVESTMENTS, INC. | 50.00 +50.0 (+100.0%) | 244.00 +244.0 (+100.0%) | 0.00% +0.001 pp | 0.00% +0.000 pp | USD4.88 +0.0% | 1 qtrs NEW |
| 34 | JONES FINANCIAL COMPANIES LLLP | 31.00 +— (+0.0%) | 151.00 +13.0 (+9.4%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD1.71 +185.4% | 4 qtrs — |
| 35 | NEWEDGE ADVISORS, LLC | 27.00 +27.0 (+100.0%) | 132.00 +132.0 (+100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD4.85 +0.6% | 1 qtrs NEW |
| 36 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | — -10.4K (-100.0%) | — -49.1K (-100.0%) | 0.00% -0.098 pp | 0.00% +0.000 pp | USD— | 5 qtrs SOLD |
| 37 | UBS GROUP AG | — -66.0 (-100.0%) | — -312.0 (-100.0%) | 0.00% -0.001 pp | 0.00% +0.000 pp | USD— | 15 qtrs SOLD |
| 38 | BARCLAYS PLC | — -106.0 (-100.0%) | — -501.0 (-100.0%) | 0.00% -0.001 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 15 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | iShares Micro-Cap ETF IWC | 0.00% | 64.4K | 0.60% |
| 2 | Dimensional - US Core Equity 1 ETF DCOR | 0.00% | 8.7K | 0.14% |
| 3 | Vanguard Extended Market ETF VXF | 0.00% | 242.3K | 0.05% |
| 4 | Dimensional - US Sustainability Core 1 ETF DFSU | 0.00% | 1.4K | 0.15% |
| 5 | Dimensional - US Core Equity 2 ETF DFAC | 0.00% | 16.9K | 0.17% |
| 6 | Vanguard U.S. Total Market Index ETF (CAD-hedged) VUS.TO | 0.00% | 205.90 | 0.17% |
| 7 | Vanguard U.S. Total Market Shares Index ETF VTS.AX | 0.00% | 1.0K | 0.03% |
| 8 | Vanguard U.S. Total Market Index ETF VUN.TO | 0.00% | 2.8K | 0.17% |
| 9 | Vanguard Total Stock Market ETF VTI | 0.00% | 476.3K | 0.03% |
| 10 | Vanguard All-Equity ETF Portfolio VEQT.TO | 0.00% | 1.0K | 0.22% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
2.00
Bullish
Ratio by volume
1.04
Neutral
Buys
4
Sells
2
Shares acquired
196.5K
Shares disposed
188.9K
Cash buys
—
Cash sales
—
Net activity
+7,610
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-23 | Krandel Judy | Officer | M-Exempt | A | Common Stock | 68,861 | 1.71 | 117.8K | 68,861 | D | ↗ |
| 2026-03-23 | Banks Robert R. Jr. | Officer | M-Exempt | D | Stock Option (right to buy) | 120,000 | 1.44 | 172.8K | 237,165 | D | ↗ |
| 2026-03-16 | Krandel Judy | Officer | A-Award | A | Stock Option (right to buy) | 4,000 | 2.92 | 11.7K | 4,000 | D | ↗ |
| 2026-03-16 | Amron Arthur H | Director | A-Award | A | Common Stock | 3,610 | 0.00 | — | 134,882 | D | ↗ |
| 2025-11-10 | Spandow Oliver J. | Director | A-Award | A | Common Stock | 8,036 | 0.00 | — | 122,881 | D | ↗ |
| 2025-11-10 | Nettis Lisa Marie | Director | A-Award | A | Common Stock | 1,622 | 0.00 | — | 1,622 | D | ↗ |
| 2025-11-10 | Amron Arthur H | Director | A-Award | A | Common Stock | 5,391 | 0.00 | — | 131,272 | D | ↗ |
| 2025-08-11 | Nettis Lisa Marie | Director | A-Award | A | Stock Option (right to buy) | 13,229 | 4.49 | 59.4K | 13,229 | D | ↗ |
| 2025-06-16 | Nettis Lisa Marie | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2025-03-27 | Krandel Judy | Officer | A-Award | A | Stock Option (right to buy) | 54,359 | 1.68 | 91.3K | 54,359 | D | ↗ |
| 2025-01-01 | Spandow Oliver J. | Director | A-Award | A | Stock Option (Right to Buy) | 7,050 | 1.47 | 10.4K | 7,050 | D | ↗ |
| 2025-01-01 | Lask Alisa | Director | A-Award | A | Stock Option (right to buy) | 7,050 | 1.47 | 10.4K | 7,050 | D | ↗ |
| 2025-01-01 | Harris Joseph Michael | Director | A-Award | A | Stock Option (right to buy) | 7,050 | 1.47 | 10.4K | 7,050 | D | ↗ |
| 2025-01-01 | Amron Arthur H | Director | A-Award | A | Common Stock | 22,418 | 0.00 | — | 125,881 | D | ↗ |
| 2024-05-30 | Amron Arthur H | Director | P-Purchase | A | Common Stock | 3,000 | 2.24 | 6.7K | 103,463 | — | ↗ |
| 2024-05-28 | Amron Arthur H | Director | P-Purchase | A | Common Stock | 2,000 | 2.22 | 4.4K | 100,463 | — | ↗ |
| 2024-05-16 | Banks Robert R. Jr. | Director / Officer | P-Purchase | A | Common Stock | 50,000 | 2.24 | 112.1K | 70,000 | — | ↗ |
| 2024-05-14 | Spandow Oliver J. | Director | A-Award | A | Stock Option (Right to Buy) | 7,323 | 2.14 | 15.7K | 7,323 | — | ↗ |
| 2024-05-14 | Lask Alisa | Director | A-Award | A | Stock Option (right to buy) | 7,323 | 2.14 | 15.7K | 7,323 | — | ↗ |
| 2024-05-14 | Harris Joseph Michael | Director | A-Award | A | Stock Option (right to buy) | 7,323 | 2.14 | 15.7K | 7,323 | — | ↗ |
| 2024-05-14 | Banks Robert R. Jr. | Director / Officer | A-Award | A | Stock Option (right to buy) | 10,406 | 2.14 | 22.3K | 10,406 | — | ↗ |
| 2024-05-14 | Amron Arthur H | Director | A-Award | A | Stock Option (Right to Buy) | 7,323 | 2.14 | 15.7K | 7,323 | — | ↗ |
| 2024-03-13 | WEXFORD CAPITAL LP | 10% Owner | J-Other | D | Common Stock | 91,463 | 0.00 | — | 56,060 | — | ↗ |
| 2024-03-13 | Amron Arthur H | Director | J-Other | A | Common stock | 91,463 | 0.00 | — | 98,463 | — | ↗ |
| 2024-03-12 | Amron Arthur H | Director | P-Purchase | A | Common stock | 7,000 | 2.45 | 17.1K | 7,000 | — | ↗ |
| 2023-12-13 | Spandow Oliver J. | Director | A-Award | A | Common Stock | 14,294 | 0.00 | — | 81,604 | — | ↗ |
| 2023-12-13 | Lask Alisa | Director | A-Award | A | Common Stock | 9,291 | 0.00 | — | 48,629 | — | ↗ |
| 2023-12-13 | Harris Joseph Michael | Director | A-Award | A | Common Stock | 9,291 | 0.00 | — | 17,693 | — | ↗ |
| 2023-12-13 | Amron Arthur H | Director | A-Award | A | Common Stock | 9,291 | 0.00 | — | 9,291 | — | ↗ |
| 2023-12-07 | Banks Robert R. Jr. | Director / Officer | P-Purchase | A | Common Stock | 18,000 | 2.20 | 39.6K | 20,000 | — | ↗ |
| 2023-11-01 | Krandel Judy | Officer | A-Award | A | Stock Option (right to buy) | 122,524 | 1.71 | 209.5K | 122,524 | — | ↗ |
| 2023-08-15 | Banks Robert R. Jr. | Director / Officer | P-Purchase | A | Common Stock | 1,901 | 1.69 | 3.2K | 2,000 | — | ↗ |
| 2023-08-14 | Banks Robert R. Jr. | Director / Officer | P-Purchase | A | Common Stock | 99 | 1.50 | 148.50 | 99 | — | ↗ |
| 2023-05-11 | Banks Robert R. Jr. | Director / Officer | — | D | Stock Option (right to buy) | 357,165 | 1.44 | 514.3K | 0 | — | ↗ |
| 2023-01-05 | Spandow Oliver J. | Director | A-Award | A | Common Stock | 42,481 | 0.00 | — | 67,310 | — | ↗ |
| 2023-01-05 | Lask Alisa | Director | A-Award | A | Common Stock | 27,613 | 0.00 | — | 39,338 | — | ↗ |
| 2023-01-05 | Harris Joseph Michael | Director | A-Award | A | Common Stock | 8,402 | 0.00 | — | 8,402 | — | ↗ |
| 2023-01-05 | Gwydir Tom | Director | A-Award | A | Common Stock | 27,613 | 0.00 | — | 43,226 | — | ↗ |
| 2023-01-05 | Amron Arthur H | Director | A-Award | A | Common Stock | 27,613 | 0.00 | — | 27,613 | — | ↗ |
| 2022-09-06 | Harris Joseph Michael | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-03-05 | Astor Andrew | Director / Officer | M-Exempt | A | Common Stock | 14,815 | 2.70 | 40.0K | 92,773 | — | ↗ |
| 2022-02-16 | Lobo Wesley S. | Officer | F-InKind | D | Common Stock | 6,389 | 4.80 | 30.7K | 35,168 | — | ↗ |
| 2021-12-14 | Spandow Oliver J. | Director | A-Award | A | Common Stock | 5,429 | 0.00 | — | 24,829 | — | ↗ |
| 2021-12-14 | Lask Alisa | Director | A-Award | A | Common Stock | 4,582 | 0.00 | — | 11,725 | — | ↗ |
| 2021-12-14 | Gwydir Tom | Director | A-Award | A | Common Stock | 4,582 | 0.00 | — | 15,613 | — | ↗ |
| 2021-12-14 | Astor Andrew | Director / Officer | A-Award | A | Stock Option (right to buy) | 38,612 | 6.82 | 263.3K | 38,612 | — | ↗ |
| 2021-12-14 | Amron Arthur H | Director | A-Award | A | Stock Option (Right to Buy) | 7,062 | 6.82 | 48.2K | 7,062 | — | ↗ |
| 2021-09-01 | Lobo Wesley S. | Officer | A-Award | A | Stock Option (right to buy) | 57,368 | 8.47 | 485.9K | 57,368 | — | ↗ |
| 2021-08-20 | Lobo Wesley S. | Officer | P-Purchase | A | Common Stock | 1,000 | 7.92 | 7.9K | 41,557 | — | ↗ |
| 2021-08-18 | Gwydir Tom | Director | P-Purchase | A | Common Stock | 5,000 | 7.64 | 38.2K | 11,031 | — | ↗ |
| 2021-08-18 | Astor Andrew | Director / Officer | P-Purchase | A | Common Stock | 2,500 | 7.77 | 19.4K | 77,958 | — | ↗ |
| 2021-08-17 | Astor Andrew | Director / Officer | P-Purchase | A | Common Stock | 2,500 | 7.67 | 19.2K | 75,458 | — | ↗ |
| 2021-06-01 | WEXFORD CAPITAL LP | Director / 10% Owner | X-InTheMoney | D | Common Stock Warrants | 66,667 | 2.70 | 180.0K | 0 | — | ↗ |
| 2021-05-27 | Evans Daron | Officer | F-InKind | D | Common Stock | 349 | 2.70 | 942.30 | 8,947 | — | ↗ |
| 2021-05-24 | Evans Daron | Officer | X-InTheMoney | A | Common Stock | 1,111 | 2.70 | 3.0K | 9,296 | — | ↗ |
| 2021-02-16 | Lobo Wesley S. | Officer | A-Award | A | Stock Optoin (right to buy) | 114,178 | 8.66 | 988.8K | 114,178 | — | ↗ |
| 2021-01-27 | WEXFORD CAPITAL LP | — | M-Exempt | D | Stock Option (Right to Buy) | 3,765 | 3.60 | 13.6K | 3,765 | — | ↗ |
| 2021-01-06 | WEXFORD CAPITAL LP | — | A-Award | A | Common Stock | 3,196 | 0.00 | — | 3,196 | — | ↗ |
| 2021-01-06 | Spandow Oliver J. | Director | A-Award | A | Common Stock | 3,666 | 0.00 | — | 19,400 | — | ↗ |
| 2021-01-06 | PERSEN MALCOLM C | Director | A-Award | A | Common Stock | 5,921 | 0.00 | — | 48,774 | — | ↗ |
| 2021-01-06 | Lask Alisa | Director | A-Award | A | Common Stock | 3,666 | 0.00 | — | 7,143 | — | ↗ |
| 2021-01-06 | Gwydir Tom | Director | A-Award | A | Stock Option (right to buy) | 6,850 | 8.06 | 55.2K | 6,850 | — | ↗ |
| 2021-01-06 | AMRON ARTHUR H | Director | A-Award | A | Stock Option (Right to Buy) | 6,850 | 8.06 | 55.2K | 6,850 | — | ↗ |
| 2020-11-19 | Astor Andrew | Director / Officer | P-Purchase | A | Common Stock | 1,000 | 5.87 | 5.9K | 72,958 | — | ↗ |
| 2020-11-18 | Spandow Oliver J. | Director | P-Purchase | A | Common Stock | 1,500 | 5.83 | 8.7K | 15,734 | — | ↗ |
| 2020-11-06 | D'Agostino Daniel S. | Officer | — | D | Stock Option (right to buy) | 103,973 | 6.71 | 697.7K | 0 | — | ↗ |
| 2020-10-15 | WEXFORD CAPITAL LP | — | A-Award | A | Common Stock, par value $0.001 | 166,667 | 6.00 | 1.00M | 3,605,471 | — | ↗ |
| 2020-08-24 | Astor Andrew | Director / Officer | A-Award | A | Stock Option (right to buy) | 152,064 | 7.07 | 1.08M | 152,064 | — | ↗ |
| 2020-08-19 | Astor Andrew | Director / Officer | P-Purchase | A | Common Stock | 950 | 7.40 | 7.0K | 71,958 | — | ↗ |
| 2020-05-28 | Astor Andrew | Officer | P-Purchase | A | Common Stock | 1,000 | 6.96 | 7.0K | 71,008 | — | ↗ |
| 2020-05-11 | PERSEN MALCOLM C | Director | X-InTheMoney | A | Common Stock | 1,732 | 7.65 | 13.2K | 5,194 | — | ↗ |
| 2020-03-12 | Evans Daron | Director / Officer | P-Purchase | A | Common Stock | 2,500 | 6.65 | 16.6K | 134,215 | — | ↗ |
| 2020-03-12 | Astor Andrew | Officer | P-Purchase | A | Common Stock | 1,000 | 6.70 | 6.7K | 70,008 | — | ↗ |
| 2020-03-05 | Evans Daron | Director / Officer | P-Purchase | A | Common Stock | 2,500 | 8.44 | 21.1K | 131,715 | — | ↗ |
| 2020-03-05 | Astor Andrew | Officer | P-Purchase | A | Common Stock | 700 | 8.46 | 5.9K | 69,008 | — | ↗ |
| 2020-02-01 | Evans Daron | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 97,076 | 5.40 | 524.2K | 242,690 | — | ↗ |
| 2020-02-01 | Astor Andrew | Officer | A-Award | A | Stock Option (right to buy) | 13,958 | 2.64 | 36.8K | 46,525 | — | ↗ |
| 2019-12-16 | Spandow Oliver J. | Director | A-Award | A | Stock Option (Right to Buy) | 5,568 | 8.57 | 47.7K | 5,568 | — | ↗ |
| 2019-12-16 | PERSEN MALCOLM C | Director | A-Award | A | Common Stock | 5,437 | 0.00 | — | 42,853 | — | ↗ |
| 2019-12-16 | Mieyal Paul A | Director | A-Award | A | Stock Option (Right to Buy) | 5,568 | 8.57 | 47.7K | 5,568 | — | ↗ |
| 2019-12-16 | Lask Alisa | Director | A-Award | A | Stock Option (right to buy) | 5,568 | 8.57 | 47.7K | 5,568 | — | ↗ |
| 2019-12-16 | Gwydir Tom | Director | A-Award | A | Stock Option (right to buy) | 5,568 | 8.57 | 47.7K | 5,568 | — | ↗ |
| 2019-12-16 | Evans Daron | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 20,000 | 8.57 | 171.4K | 20,000 | — | ↗ |
| 2019-12-16 | Astor Andrew | Officer | A-Award | A | Stock Option (right to buy) | 20,000 | 8.30 | 166.0K | 20,000 | — | ↗ |
| 2019-12-16 | AMRON ARTHUR H | Director | A-Award | A | Stock Option (Right to Buy) | 5,568 | 8.57 | 47.7K | 5,568 | — | ↗ |
| 2019-11-25 | Spandow Oliver J. | Director | P-Purchase | A | Common Stock | 1,000 | 8.17 | 8.2K | 10,786 | — | ↗ |
| 2019-11-18 | Evans Daron | Director / Officer | P-Purchase | A | Common Stock | 1,000 | 8.35 | 8.4K | 119,933 | — | ↗ |
| 2019-11-18 | Astor Andrew | Officer | P-Purchase | A | Common Stock | 750 | 8.38 | 6.3K | 61,460 | — | ↗ |
| 2019-09-11 | Lask Alisa | Director | P-Purchase | A | Common Stock | 250 | 6.45 | 1.6K | 250 | — | ↗ |
| 2019-08-22 | Evans Daron | Director / Officer | P-Purchase | A | Common Stock | 2,000 | 6.92 | 13.8K | 118,933 | — | ↗ |
| 2019-08-22 | Astor Andrew | Officer | P-Purchase | A | Common Stock | 1,500 | 6.97 | 10.5K | 60,710 | — | ↗ |
| 2019-08-09 | Evans Daron | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 36,404 | 5.40 | 196.6K | 145,614 | — | ↗ |
| 2019-08-09 | Astor Andrew | Officer | A-Award | A | Stock Option (right to buy) | 9,305 | 2.64 | 24.6K | 32,567 | — | ↗ |
| 2019-06-14 | Evans Daron | Director / Officer | P-Purchase | A | Common Stock | 11,172 | 0.60 | 6.7K | 1,052,426 | — | ↗ |
| 2019-06-14 | Astor Andrew | Officer | P-Purchase | A | Common Stock | 35,000 | 0.64 | 22.4K | 532,903 | — | ↗ |
| 2019-04-29 | Gwydir Tom | Director | A-Award | A | Stock Option (right to buy) | 86,641 | 0.59 | 51.1K | 86,641 | — | ↗ |
| 2019-02-08 | Lask Alisa | Director | A-Award | A | Stock Option (right to buy) | 86,546 | 0.58 | 50.2K | 86,546 | — | ↗ |
| 2018-12-19 | Spandow Oliver J. | Director | A-Award | A | Stock Option (Right to Buy) | 46,457 | 0.65 | 30.2K | 46,457 | — | ↗ |
| 2018-12-19 | Pinto Moshe | Director | A-Award | A | Stock Option (Right to Buy) | 46,457 | 0.65 | 30.2K | 46,457 | — | ↗ |
| 2018-12-19 | PERSEN MALCOLM C | Director | A-Award | A | Stock Option (Right to Buy) | 46,457 | 0.65 | 30.2K | 46,457 | — | ↗ |
| 2018-12-19 | Mieyal Paul A | Director | A-Award | A | Stock Option (Right to Buy) | 46,457 | 0.65 | 30.2K | 46,457 | — | ↗ |
| 2018-12-19 | Astor Andrew | Officer | A-Award | A | Stock Option (right to buy) | 200,000 | 0.65 | 130.0K | 200,000 | — | ↗ |
| 2018-12-19 | AMRON ARTHUR H | Director | A-Award | A | Stock Option (Right to Buy) | 46,457 | 0.65 | 30.2K | 46,457 | — | ↗ |
| 2018-12-14 | Spandow Oliver J. | Director | A-Award | A | Common Stock | 18,030 | 0.00 | — | 88,080 | — | ↗ |
| 2018-12-14 | Pinto Moshe | Director | A-Award | A | Common Stock | 73,343 | 0.00 | — | 229,788 | — | ↗ |
| 2018-12-14 | PERSEN MALCOLM C | Director | A-Award | A | Common Stock | 71,509 | 0.00 | — | 336,750 | — | ↗ |
| 2018-12-14 | Mieyal Paul A | Director | A-Award | A | Common Stock | 47,673 | 0.00 | — | 47,673 | — | ↗ |
| 2018-12-14 | Evans Daron | Director / Officer | A-Award | A | Common Stock | 108,296 | 0.00 | — | 1,001,254 | — | ↗ |
| 2018-12-14 | Astor Andrew | Officer | A-Award | A | Common Stock | 44,111 | 0.00 | — | 497,903 | — | ↗ |
| 2018-12-14 | AMRON ARTHUR H | Director | A-Award | A | Common Stock | 47,673 | 0.00 | — | 47,673 | — | ↗ |
| 2018-08-10 | Spandow Oliver J. | Director | A-Award | A | Stock Option (Right to Buy) | 85,199 | 0.62 | 52.8K | 85,199 | — | ↗ |
| 2018-05-14 | Evans Daron | Director / Officer | X-InTheMoney | A | Common Stock | 40,000 | 0.30 | 12.0K | 95,000 | — | ↗ |
| 2018-05-14 | Astor Andrew | Officer | X-InTheMoney | A | Common Stock | 33,333 | 0.30 | 10.0K | 453,792 | — | ↗ |
| 2018-04-10 | Evans Daron | Director / Officer | P-Purchase | A | Common Stock | 55,000 | 0.45 | 24.8K | 55,000 | — | ↗ |
| 2018-04-10 | Astor Andrew | Director / Officer | P-Purchase | A | Common Stock | 80,000 | 0.45 | 36.0K | 420,459 | — | ↗ |
| 2018-03-09 | Astor Andrew | Officer | P-Purchase | A | Common Stock | 5,000 | 0.48 | 2.4K | 340,459 | — | ↗ |
| 2018-02-01 | Evans Daron | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 218,419 | 0.60 | 131.1K | 982,887 | — | ↗ |
| 2017-12-20 | Pinto Moshe | Director | A-Award | A | Stock Option (Right to Buy) | 40,284 | 0.50 | 20.1K | 40,284 | — | ↗ |
| 2017-12-20 | PERSEN MALCOLM C | Director | A-Award | A | Common Stock | 113,636 | 0.00 | — | 265,241 | — | ↗ |
| 2017-12-20 | Mieyal Paul A | Director | A-Award | A | Non-qualified stock option | 40,284 | 0.50 | 20.1K | 40,284 | — | ↗ |
| 2017-12-20 | Evans Daron | Director / Officer | A-Award | A | Common Stock | 180,000 | 0.00 | — | 892,958 | — | ↗ |
| 2017-12-20 | Astor Andrew | Officer | A-Award | A | Common Stock | 120,417 | 0.00 | — | 335,459 | — | ↗ |
| 2017-12-20 | AMRON ARTHUR H | Director | A-Award | A | Non-Qualified Stock Option | 40,284 | 0.50 | 20.1K | 40,284 | — | ↗ |
| 2017-12-04 | Astor Andrew | Officer | P-Purchase | A | Common Stock | 8,333 | 0.50 | 4.2K | 215,042 | — | ↗ |
| 2017-12-01 | Astor Andrew | Officer | P-Purchase | A | Common Stock | 10,000 | 0.50 | 5.0K | 206,709 | — | ↗ |
| 2017-09-06 | Evans Daron | Director / Officer | P-Purchase | A | Common Stock | 28,000 | 0.24 | 6.8K | 712,958 | — | ↗ |
| 2017-09-05 | Evans Daron | Director / Officer | P-Purchase | A | Common Stock | 1,580 | 0.24 | 371.30 | 684,958 | — | ↗ |
| 2017-08-28 | Astor Andrew | Officer | P-Purchase | A | Common Stock | 4,000 | 0.27 | 1.1K | 196,709 | — | ↗ |
| 2017-08-22 | Evans Daron | Director / Officer | P-Purchase | A | Common Stock | 2,000 | 0.25 | 500.00 | 53,666 | — | ↗ |
| 2017-08-11 | Evans Daron | Director / Officer | P-Purchase | A | Common Stock | 70,000 | 0.26 | 18.2K | 683,378 | — | ↗ |
| 2017-08-11 | Astor Andrew | Officer | P-Purchase | A | Common Stock | 20,000 | 0.26 | 5.2K | 186,666 | — | ↗ |
| 2017-06-16 | Astor Andrew | Officer | L-Small | A | Common Stock | 43 | 0.27 | 11.40 | 186,709 | — | ↗ |
| 2017-06-12 | Evans Daron | Director / Officer | P-Purchase | A | Common Stock | 3,961 | 0.26 | 1.0K | 613,378 | — | ↗ |
| 2017-06-09 | Evans Daron | Director / Officer | P-Purchase | A | Common Stock | 10,000 | 0.26 | 2.6K | 51,666 | — | ↗ |
| 2017-05-19 | Evans Daron | Director / Officer | P-Purchase | A | Common Stock | 7,500 | 0.26 | 1.9K | 609,417 | — | ↗ |
| 2017-05-18 | Evans Daron | Director / Officer | P-Purchase | A | Common Stock | 22,500 | 0.26 | 5.7K | 601,917 | — | ↗ |
| 2017-05-01 | Astor Andrew | Officer | A-Award | A | Stock Option (right to buy) | 209,355 | 0.29 | 61.3K | 209,355 | — | ↗ |
| 2017-03-31 | Evans Daron | Director / Officer | A-Award | A | Common Stock | 17,756 | 0.00 | — | 579,417 | — | ↗ |
| 2017-03-17 | Evans Daron | Director / Officer | P-Purchase | A | Common Stock | 41,666 | 0.30 | 12.5K | 41,666 | — | ↗ |
| 2017-03-17 | Astor Andrew | Officer | P-Purchase | A | Warrants (right to buy) | 166,666 | 0.30 | 50.0K | 166,666 | — | ↗ |
| 2017-02-13 | Astor Andrew | Officer | A-Award | A | Stock Option (right to buy) | 289,785 | 0.46 | 133.3K | 289,785 | — | ↗ |
| 2016-12-23 | Evans Daron | Director / Officer | A-Award | A | Common Stock | 213,068 | 0.00 | — | 561,661 | — | ↗ |
| 2016-12-14 | Evans Daron | Director / Officer | A-Award | A | Common Stock | 9,165 | 0.00 | — | 348,593 | — | ↗ |
| 2016-12-07 | Evans Daron | Director / Officer | P-Purchase | A | Common Stock | 4,069 | 0.32 | 1.3K | 339,428 | — | ↗ |
| 2016-12-05 | Evans Daron | Director / Officer | P-Purchase | A | Common Stock | 6,020 | 0.34 | 2.0K | 335,359 | — | ↗ |
| 2016-12-01 | Evans Daron | Director / Officer | P-Purchase | A | Common Stock | 40,599 | 0.32 | 13.0K | 324,739 | — | ↗ |
| 2016-11-30 | Evans Daron | Director / Officer | P-Purchase | A | Common Stock | 931 | 0.29 | 269.99 | 284,140 | — | ↗ |
| 2016-08-24 | Pinto Moshe | Director | A-Award | A | Stock Option (Right to Buy) | 33,880 | 0.40 | 13.6K | 33,880 | — | ↗ |
| 2016-08-24 | PERSEN MALCOLM C | Director | A-Award | A | Common Stock | 113,636 | 0.00 | — | 151,605 | — | ↗ |
| 2016-08-24 | Mieyal Paul A | Director | A-Award | A | Non-Qualified Stock Option | 33,880 | 0.40 | 13.6K | 33,880 | — | ↗ |
| 2016-08-24 | AMRON ARTHUR H | Director | A-Award | A | Common Stock | 73,864 | 0.00 | — | 73,864 | — | ↗ |
| 2016-06-03 | Lambda Investors LLC | Director / 10% Owner | A-Award | A | Common Stock Warrant | 600,000 | 0.30 | 180.0K | 600,000 | — | ↗ |
| 2016-06-03 | Evans Daron | Director / Officer | P-Purchase | A | Common Stock Warrants (Right to Buy) | 40,000 | 0.30 | 12.0K | 40,000 | — | ↗ |
| 2015-12-18 | Lambda Investors LLC | Director / 10% Owner | X-InTheMoney | A | Common Stock, par value $0.001 | 2,782,576 | 0.40 | 1.11M | 29,800,424 | — | ↗ |
| 2015-12-17 | Evans Daron | Director / Officer | A-Award | A | Common Stock | 42,840 | 0.00 | — | 283,209 | — | ↗ |
| 2015-09-29 | Lambda Investors LLC | Director / 10% Owner | X-InTheMoney | D | Class D Warrants | 11,742,100 | 0.15 | 1.76M | 0 | — | ↗ |
| 2015-09-09 | ROSENBERG MATTHEW | Director | A-Award | A | Common Stock | 58,240 | 0.00 | — | 847,935 | — | ↗ |
| 2015-09-09 | Pinto Moshe | Director | A-Award | A | Common Stock | 8,717 | 0.00 | — | 8,717 | — | ↗ |
| 2015-09-09 | PERSEN MALCOLM C | Director | A-Award | A | Common Stock | 16,951 | 0.00 | — | 16,951 | — | ↗ |
| 2015-09-09 | Mieyal Paul A | Director | A-Award | A | Common Stock | 58,240 | 0.00 | — | 58,240 | — | ↗ |
| 2015-09-09 | Evans Daron | Director / Officer | A-Award | A | Common Stock | 70,610 | 0.00 | — | 240,369 | — | ↗ |
| 2015-09-09 | CENTELLA LAWRENCE J | Director | A-Award | A | Common Stock | 97,135 | 0.00 | — | 218,467 | — | ↗ |
| 2015-09-09 | AMRON ARTHUR H | Director | A-Award | A | Common Stock | 58,240 | 0.00 | — | 58,240 | — | ↗ |
| 2015-08-31 | Evans Daron | Director / Officer | P-Purchase | A | Common Stock | 10,000 | 0.57 | 5.7K | 169,759 | — | ↗ |
| 2015-08-28 | Evans Daron | Director / Officer | P-Purchase | A | Common Stock | 10,000 | 0.60 | 6.0K | 159,759 | — | ↗ |
| 2015-08-27 | Evans Daron | Director / Officer | P-Purchase | A | Common Stock | 19,175 | 0.56 | 10.7K | 144,759 | — | ↗ |
| 2015-08-20 | Evans Daron | Director / Officer | P-Purchase | A | Common Stock | 27,000 | 0.56 | 15.1K | 125,584 | — | ↗ |
| 2015-08-19 | Evans Daron | Director / Officer | P-Purchase | A | Common Stock | 24,500 | 0.50 | 12.3K | 98,584 | — | ↗ |
| 2015-08-14 | Pinto Moshe | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2015-05-12 | ROSENBERG MATTHEW | Director | P-Purchase | A | Common Stock | 200,000 | 0.67 | 134.0K | 789,695 | — | ↗ |
| 2015-05-12 | PERSEN MALCOLM C | Director | P-Purchase | A | Common Stock | 31,160 | 0.67 | 20.9K | 31,160 | — | ↗ |
| 2015-05-07 | PERSEN MALCOLM C | Director | A-Award | A | Stock Option (Right to Buy) | 56,981 | 0.79 | 45.0K | 56,981 | — | ↗ |
| 2015-04-15 | Evans Daron | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 764,468 | 0.60 | 458.7K | 764,468 | — | ↗ |
| 2014-12-18 | ROSENBERG MATTHEW | Director | J-Other | A | Common Stock | 374,997 | 0.60 | 225.0K | 589,695 | — | ↗ |
| 2014-12-18 | Lambda Investors LLC | Director / 10% Owner | J-Other | A | Common Stock, par value $0.001 | 14,853 | 0.60 | 8.9K | 190,446 | — | ↗ |
| 2014-12-18 | Houghton John C. | Director / Officer | J-Other | A | Common Stock | 7,885 | 0.60 | 4.7K | 74,139 | — | ↗ |
| 2014-12-18 | Evans Daron | Director | J-Other | A | Common Stock | 21,239 | 0.60 | 12.7K | 74,084 | — | ↗ |
| 2014-12-18 | CENTELLA LAWRENCE J | Director | J-Other | A | Common Stock | 10,202 | 0.60 | 6.1K | 121,332 | — | ↗ |
| 2014-11-06 | ROSENBERG MATTHEW | Director | A-Award | A | Common Stock | 12,698 | 0.00 | — | 214,698 | — | ↗ |
| 2014-11-06 | Mieyal Paul A | Director | A-Award | A | Common Stock | 25,395 | 0.00 | — | 25,395 | — | ↗ |
| 2014-11-06 | Evans Daron | Director | A-Award | A | Common Stock | 43,194 | 0.00 | — | 52,845 | — | ↗ |
| 2014-11-06 | CENTELLA LAWRENCE J | Director | A-Award | A | Common Stock | 25,395 | 0.00 | — | 111,130 | — | ↗ |
| 2014-11-06 | AMRON ARTHUR H | Director | A-Award | A | Common Stock | 25,395 | 0.00 | — | 25,395 | — | ↗ |
| 2014-05-16 | ROSENBERG MATTHEW | Director | A-Award | A | Non-Qualified Stock Option (right to buy) | 48,864 | 0.79 | 38.6K | 48,864 | — | ↗ |
| 2014-03-26 | Mieyal Paul A | Director | A-Award | A | Non Qualified Stock Option (right to buy) | 26,598 | 0.46 | 12.2K | 26,598 | — | ↗ |
| 2014-03-26 | Evans Daron | Director | A-Award | A | Non-Qualified Stock Option (right to buy) | 75,361 | 0.46 | 34.7K | 75,361 | — | ↗ |
| 2014-03-26 | CENTELLA LAWRENCE J | Director | A-Award | A | Non-Qualified Stock Option (right to buy) | 26,598 | 0.46 | 12.2K | 26,598 | — | ↗ |
| 2014-03-26 | AMRON ARTHUR H | Director | A-Award | A | Non Qualiffied Stock Option (right to buy) | 26,598 | 0.46 | 12.2K | 26,598 | — | ↗ |
| 2014-03-21 | Evans Daron | Director | J-Other | A | Common Stock | 2,151 | 0.30 | 645.30 | 9,651 | — | ↗ |
| 2014-03-21 | CENTELLA LAWRENCE J | Director | J-Other | A | Common Stock | 19,105 | 0.30 | 5.7K | 85,735 | — | ↗ |
| 2014-03-14 | Lambda Investors LLC | 10% Owner | J-Other | A | Common Stock, par value $0.001 | 5,250,264 | 0.30 | 1.58M | 11,971,940 | — | ↗ |
| 2014-02-05 | Houghton John C. | Director / Officer | A-Award | A | Incentive Stock Option (right to buy) | 35,000 | 0.33 | 11.6K | 35,000 | — | ↗ |
| 2013-12-31 | Scibetta James S | Director | A-Award | A | Non-Qualified Stock Option (right to buy) | 60,440 | 0.42 | 25.4K | 60,440 | — | ↗ |
| 2013-12-31 | Mieyal Paul A | Director | A-Award | A | Common Stock | 19,733 | 0.00 | — | 19,733 | — | ↗ |
| 2013-12-31 | CENTELLA LAWRENCE J | Director | A-Award | A | Common Stock | 19,733 | 0.00 | — | 66,630 | — | ↗ |
| 2013-12-31 | AMRON ARTHUR H | Director | A-Award | A | Common Stock | 19,733 | 0.00 | — | 19,733 | — | ↗ |
| 2013-11-29 | Evans Daron | Director | — | D | Nephros, Inc. Common Stock | 0 | 0.00 | — | 7,500 | — | ↗ |
| 2013-08-20 | Scibetta James S | Director | A-Award | A | Common Stock | 12,078 | 0.00 | — | 64,134 | — | ↗ |
| 2013-08-20 | Mieyal Paul A | Director | A-Award | A | Common Stock | 5,417 | 0.00 | — | 28,763 | — | ↗ |
| 2013-08-20 | CENTELLA LAWRENCE J | Director | A-Award | A | Common Stock | 5,417 | 0.00 | — | 46,897 | — | ↗ |
Executive team
Top executives
EBIT / Employee
37.0K
Shares Outstanding
10.86M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2024 | Robert Banks President and Chief Executive Officer | 350.0K | 35.0K | — | 14.7K | — | 10.5K | 410.2K | 3.58% | ↗ |
| 2 | 2024 | Judy Krandel Chief Financial Officer | 141.7K | 7.0K | — | — | — | — | 148.7K | 0.00% | ↗ |
| 3 | 2023 | Robert Banks President and Chief Executive Officer | 229.3K | 108.8K | — | 350.0K | — | 6.9K | 695.0K | 50.36% | ↗ |
| 4 | 2023 | Andrew Astor Former President, Chief Executive Officer and Chief Financial Officer | 302.9K | 91.4K | — | 142.6K | — | 8.6K | 545.5K | 26.14% | ↗ |
| 5 | 2023 | Judy Krandel Chief Financial Officer | 23.3K | 7.0K | — | 137.2K | — | — | 167.6K | 81.89% | ↗ |
| 6 | 2022 | Andrew Astor Former President, Chief Executive Officer and Chief Financial Officer | 325.0K | — | — | — | — | 9.8K | 334.8K | 0.00% | ↗ |
| 7 | 2022 | Andrew Astor President, Chief Executive Officer and Chief Financial Officer | 325.0K | — | — | — | — | 9.8K | 334.8K | 0.00% | ↗ |
| 8 | 2022 | Wesley Lobo Chief Marketing Officer | 206.3K | — | — | — | — | 6.2K | 212.4K | 0.00% | ↗ |
| 9 | 2021 | Wesley Lobo Chief Marketing Officer | 240.6K | 112.4K | 351.2K | 938.7K | — | 7.2K | 1.65M | 78.17% | ↗ |
| 10 | 2021 | Andrew Astor President, Chief Executive Officer and Chief Financial Officer | 325.0K | 43.9K | — | 167.1K | — | 9.8K | 545.7K | 30.62% | ↗ |
| 11 | 2020 | Andrew Astor President, Chief Executive Officer and Chief Financial Officer | 309.0K | — | — | 680.5K | — | 9.3K | 998.8K | 68.14% | ↗ |
| 12 | 2020 | Daron Evans Chief Executive Officer of SRP, Former President and Chief Executive Officer of Nephros | 300.2K | — | — | — | — | — | 300.2K | 0.00% | ↗ |
| 13 | 2019 | Daron Evans President and Chief Executive Officer | 350.0K | 70.0K | 79.5K | 114.7K | — | 10.5K | 624.7K | 31.09% | ↗ |
| 14 | 2019 | Daron Evans Chief Executive Officer of SRP, Former President and Chief Executive Officer of Nephros | 350.0K | 70.0K | 79.5K | 114.7K | — | 10.5K | 624.7K | 31.09% | ↗ |
| 15 | 2019 | Andrew Astor President, Chief Executive Officer and Chief Financial Officer | 295.1K | 51.6K | 58.7K | 114.7K | — | 8.9K | 529.0K | 32.78% | ↗ |
| 16 | 2019 | Andrew Astor Chief Financial Officer and Chief Operating Officer | 295.1K | 51.6K | 58.7K | 114.7K | — | 8.9K | 529.0K | 32.78% | ↗ |
| 17 | 2018 | Daron Evans President and Chief Executive Officer | 350.0K | 19.7K | 67.1K | — | — | 10.5K | 447.3K | 15.01% | ↗ |
| 18 | 2018 | Andrew Astor Chief Financial Officer and Chief Operating Officer | 256.6K | 24.1K | 27.3K | 99.4K | — | 7.7K | 415.1K | 30.53% | ↗ |
| 19 | 2017 | Daron Evans President and Chief Executive Officer | 240.0K | — | 96.7K | 340.0K | — | 7.0K | 683.8K | 63.87% | ↗ |
| 20 | 2017 | Andrew Astor Chief Financial Officer | 193.0K | — | 60.2K | 341.1K | — | 6.1K | 600.4K | 66.84% | ↗ |
| 21 | 2017 | Andrew Astor Chief Financial Officer and Chief Operating Officer | 193.0K | — | 60.2K | 341.1K | — | 6.1K | 600.4K | 66.84% | ↗ |
| 22 | 2016 | Daron Evans President and Chief Executive Officer | 240.0K | — | 68.2K | — | — | 17.9K | 326.1K | 20.91% | ↗ |
| 23 | 2013 | John C. Houghton President, Chief Executive Officer and Acting Chief Financial Officer | 350.0K | — | 47.0K | 23.6K | — | 31.7K | 452.3K | 15.62% | ↗ |
| 24 | 2013 | Gerald J. Kochanski Chief Financial Officer | 92.7K | — | — | — | — | 14.1K | 106.8K | 0.00% | ↗ |
| 25 | 2012 | John C. Houghton President and Chief Executive Officer | 242.8K | — | — | 1.13M | — | 20.7K | 1.39M | 81.03% | ↗ |
| 26 | 2012 | John C. Houghton President, Chief Executive Officer and Acting Chief Financial Officer | 242.8K | — | — | 1.13M | — | 20.7K | 1.39M | 81.03% | ↗ |
| 27 | 2012 | Gerald J. Kochanski Chief Financial Officer | 202.0K | 40.0K | — | 14.8K | — | 23.2K | 280.0K | 5.27% | ↗ |
| 28 | 2012 | Paul A. Mieyal Acting Chief Executive Officer | — | — | — | 7.3K | — | 14.8K | 22.1K | 33.05% | ↗ |
| 29 | 2011 | Gerald J. Kochanski Chief Financial Officer | 198.7K | 38.9K | — | 110.0K | — | 22.6K | 370.2K | 29.71% | ↗ |
| 30 | 2011 | Paul A. Mieyal Acting Chief Executive Officer | — | — | — | 14.1K | — | 14.8K | 28.9K | 48.75% | ↗ |
| 31 | 2011 | Paul A. Mieyal Acting Chief Executive Officer | — | — | — | 14.0K | — | 14.8K | 28.8K | 48.58% | ↗ |
| 32 | 2010 | Gerald J. Kochanski Chief Financial Officer | 190.6K | — | — | 48.6K | — | 32.1K | 271.2K | 17.92% | ↗ |
| 33 | 2010 | Paul A. Mieyal Acting Chief Executive Officer | — | — | — | — | — | 14.8K | 29.4K | 0.00% | ↗ |
| 34 | 2009 | Ernest A. Elgin III President and Chief Executive Officer | 240.0K | — | — | 160.0K | — | 23.9K | 423.9K | 37.75% | ↗ |
| 35 | 2009 | Gerald J. Kochanski Chief Financial Officer | 190.6K | — | — | 48.6K | — | 32.1K | 271.2K | 17.92% | ↗ |
| 36 | 2009 | Mark W. Lerner Chief Financial Officer | — | — | — | — | — | — | — | — | ↗ |
| 37 | 2009 | Norman J. Barta President and Chief Executive Officer | — | — | — | — | — | — | — | — | ↗ |
| 38 | 2008 | Norman J. Barta President and Chief Executive Officer | 373.8K | 18.0K | — | — | — | 37.2K | 429.1K | 0.00% | ↗ |
| 39 | 2008 | Ernest A. Elgin III President and Chief Executive Officer | 70.0K | 35.0K | — | 210.0K | — | 7.1K | 322.1K | 65.20% | ↗ |
| 40 | 2008 | Gerald J. Kochanski Chief Financial Officer | 138.8K | 18.0K | — | 143.7K | — | 19.6K | 320.1K | 44.91% | ↗ |
| 41 | 2008 | Ernest A. Elgin, III President and Chief Executive Officer | 70.0K | 35.0K | — | 14.4K | — | 7.1K | 126.5K | 11.40% | ↗ |
| 42 | 2008 | Mark W. Lerner Chief Financial Officer | 113.8K | — | — | — | — | 1.1K | 114.9K | 0.00% | ↗ |
| 43 | 2007 | Norman J. Barta President and Chief Executive Officer | 325.6K | 128.5K | — | 391.7K | — | 38.0K | 883.8K | 44.32% | ↗ |
| 44 | 2007 | Mark W. Lerner Chief Financial Officer | 180.8K | — | — | 45.6K | — | 4.2K | 230.5K | 19.76% | ↗ |
| 45 | 2007 | Gerald J. Kochanski Chief Financial Officer | — | — | — | — | — | — | — | — | ↗ |
| 46 | 2007 | Ernest A. Elgin, III President and Chief Executive Officer | — | — | — | — | — | — | — | — | ↗ |
| 47 | 2005 | Norman J. Barta, President Chief Executive Officer | 285.0K | 27.7K | — | — | — | 616.00 | 313.3K | 0.00% | ↗ |
| 48 | 2005 | Marc L. Panoff, Former Chief | 160.0K | 1.2K | — | — | — | 346.00 | 161.5K | 0.00% | ↗ |
| 49 | 2004 | Norman J. Barta, President Chief Executive Officer | 259.8K | — | — | 40.0K | — | 645.00 | 260.4K | 15.36% | ↗ |
| 50 | 2004 | Marc L. Panoff, Former Chief | 67.3K | — | — | 76.8K | — | 101.00 | 67.4K | 113.96% | ↗ |
| 51 | 2003 | Norman J. Barta, President Chief Executive Officer | 201.6K | 61.4K | — | 327.6K | — | 648.00 | 263.6K | 124.25% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Robert Banks | President, Chief Executive Officer & Director | 627.1K | male |
| Judy F. Krandel | Chief Financial Officer | 204.8K | female |
| Brianne McGuire | Director of Brand, Marketing & Business Development | — | — |
| Greg Lucas | President of Aether Water Systems | — | male |
| Judy Mazzini | Controller | — | female |
| Vashone R. Thomas | Vice President of Quality, Regulatory, & Human Resources | — | — |
ESG Rating
ESG Score History MEDICAL - INSTRUMENTS & SUPPLIES
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for NEPH
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
